Grace Therapeutics Inc (GRCE) Shares on the Rise: Short-term Analysis

A share price of Grace Therapeutics Inc [GRCE] is currently trading at $3.07, up 7.34%. An important factor to consider is whether the stock is rising or falling in short-term value. The GRCE shares have gain 7.72% over the last week, with a monthly amount glided 2.68%, and seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Grace Therapeutics Inc [NASDAQ: GRCE] stock has seen the most recent analyst activity on May 02, 2025, when TD Cowen initiated its Buy rating and assigned the stock a price target of $12. Previously, Oppenheimer downgraded its rating to Perform on September 01, 2020. On July 06, 2020, upgrade upgraded it’s rating to Buy but maintained its price target of $2 on the stock. B. Riley FBR downgraded its rating to a Neutral. B. Riley FBR initiated its recommendation with a Buy and recommended $7.75 as its price target on August 29, 2019. Oppenheimer started tracking with a Outperform rating for this stock on July 18, 2019, and assigned it a price target of $7. In a note dated June 26, 2019, H.C. Wainwright initiated an Buy rating and provided a target price of $6 on this stock.

Grace Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $1.75 and $4.97. Grace Therapeutics Inc [NASDAQ: GRCE] shares were valued at $3.07 at the most recent close of the market.

Analyzing the GRCE fundamentals

To continue investigating profitability, this company’s Return on Assets is posted at -0.22, Equity is -0.23 and Total Capital is -0.28.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.96 points at the first support level, and at 2.85 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.13, and for the 2nd resistance point, it is at 3.18.

Ratios To Look Out For

To put it in perspective, the Current Ratio for Grace Therapeutics Inc [NASDAQ:GRCE] is 6.06. On the other hand, the Quick Ratio is 6.06, and the Cash Ratio is 5.61.

Related Posts

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.